MODEL VERDICT
P3 Health Partners Inc. (PIII)
Relative Valuation•Peer multiples, Monte Carlo simulation & quality-adjusted fair value
Popular:
Composite score derived from valuation, quality, and risk factors
Quantitative model thresholds · For educational and research purposes only
Each row records the model's monthly assessment. High Conviction = the model detected notable undervaluation vs peers. Neutral = no notable divergence was found. The return column shows the actual price change over 90 days for reference. This is a quantitative observation log — not investment advice.
| Date | Assessment | Score | Price | Status | 90d Fwd Return |
|---|---|---|---|---|---|
| Feb 28, 2026 | MODERATE | 0.59 | $2.12 | CURRENT | +32.1% |
Historical model observations for research purposes only. Past quantitative patterns do not predict future results. Not a recommendation to buy, sell, or hold any security.
| Methodology | Fair Value | vs Current | Weight | Quality | Status |
|---|---|---|---|---|---|
| EV To Revenue 31 industry peers | $678.57 | +31908.0% | 4% | B | Data |
| Price / Sales 31 industry peers | $521.95 | +24520.3% | 3% | B | Model Driven |
| Weighted Output Blended model output | $543.45 | +25534.4% | 100% | 48 | SIGNIFICANTLY UNDERVALUED |
Cross-sectional regression predicting expected multiples based on growth, margins, ROIC, and beta.
| Multiple | Avg | Median | Min | Max | Std |
|---|---|---|---|---|---|
| P/B Ratio | 0.20 | 0.18 | 0.14 | 0.31 | 0.08 |
| P/S Ratio | 0.17 | 0.09 | 0.02 | 0.46 | 0.20 |
Based on our peer multiples analysis with 5 valuation metrics, the model estimates PIII's fair value at $543.45 vs the current price of $2.12, implying +25534.4% upside potential. Model verdict: Significantly Undervalued. Confidence: 48/100. This is a quantitative estimate, not a recommendation.
The blended fair value of $543.45 is calculated using four lenses: industry median multiples (40%), historical multiples (30%), forward estimates (20%), and quality-adjusted multiples (10%). Monte Carlo simulation (10,000 iterations) gives a range of $371.43 (P10) to $686.39 (P90), with a median of $526.74.
PIII's current P/E of -0.0x compares to the industry median of 19.7x (20 peers in the group). This represents a -100.2% discount to the industry. The historical average P/E is N/Ax over 0 years. Signal: Deep Discount.
4 analysts cover PIII with a consensus rating of Buy. The consensus price target is $12.50 (range: $12.50 — $12.50), implying +489.6% upside from the current price. Grade breakdown: Strong Buy (0), Buy (2), Hold (2), Sell (0), Strong Sell (0).
The model confidence score is 48/100, based on: data completeness (6), peer quality (25), historical depth (10), earnings stability (5), and model agreement (2). Cyclicality penalty: -0 points. The model shows moderate agreement across inputs.
The model flags several key risks: (1) Macro/regulatory risks are not captured in this model but remain material.
Peak earnings risk data is not available for PIII.
No. This dashboard is a quantitative research tool for educational and informational purposes only. It is not investment advice, a solicitation, or a recommendation to buy, sell, or hold any security. The operator of this platform is not a registered investment advisor (RIA), broker-dealer, or financial planner. All model outputs, fair value estimates, signals, and scenarios are the result of automated quantitative computations and should not be construed as professional financial guidance. You should consult a qualified, licensed financial advisor before making any investment decisions. Past model performance is not indicative of future results.